Rossmax International

Rossmax International FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Rossmax International (4121.TWO) as of Nov 1, 2026 is -791.86 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -812.80 % — a change of -2.58% (higher).

FCF Conversion

-791.86 %

YoY

-2.58%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Rossmax International is 2025 -791.86 % . FCF Conversion Rate (FCF/EBITDA) of Rossmax International was 2024 -812.80 % . It decreases by -2.58% higher compared to the previous year.

The Rossmax International FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-138.01 TWD
Jan 1, 2019
157.36 TWD
Jan 1, 2020
278.84 TWD
Jan 1, 2021
202.56 TWD
Jan 1, 2022
175.93 TWD
Jan 1, 2023
-2,925.82 TWD
Jan 1, 2024
-812.80 TWD
Jan 1, 2025
-791.86 TWD
The Rossmax International FCF Conversion history
YEARFCF ConversionYoY
-791.86 %-2.58%
-812.80 %-72.22%
-2,925.82 %-1,763.10%
175.93 %-13.15%
202.56 %-27.36%
278.84 %+77.20%
157.36 %-214.02%
-138.01 %-71.97%
-492.33 %-32.67%
-731.20 %-1,248.36%
63.67 %-99.25%
8,436.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossmax International Stock analysis

What does Rossmax International do? Rossmax International Ltd, listed on the Taiwan Stock Exchange under ticker 4121.TWO with ISIN TW0004121009, is a healthcare company headquartered in Taipei City, Taiwan. Founded through an IPO on November 28, 2002, the company employs 965 people. It operates within the healthcare sector, focusing on the design, manufacture, research, and development of healthcare products. Its primary product lines include digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. Rossmax distributes its products both domestically within Taiwan and internationally across markets in Europe, the Americas, and other regions. The company maintains a website at https://www.rossmax.com/ for further information. Rossmax International Ltd does not disclose specific financial figures or additional details beyond its operational scope and product offerings as provided in the source material. The company's activities are centered around healthcare innovation and product development aimed at meeting consumer health needs through technological solutions. Rossmax International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossmax International stock

FCF Conversion Rate (FCF/EBITDA) of Rossmax International is -791.86 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Rossmax International changed from -812.80 % to -791.86 %, representing a -2.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Rossmax International since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Rossmax International with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Rossmax International

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Rossmax International